POETIG
Phase 2 trial of ponatinib in patients with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) following failure of prior therapy with imatinib (POETIG trial – POnatinib after rEsisTance to Imatinib in GIST)
II
Status: Studie beendet
Zeitraum
2016
2020
Zentren
10
8
Keine Zentren gesucht
Patienten
60
45
14.04.2022
Identifier
AIO-STS-0115/ass
Kontakt
Leitung
Prof. Dr. med. Sebastian Bauer
Ansprechpartner*in
Prof. Dr. med. Sebastian Bauer
Telefon +49 201 72385011
E-Mail sebastian.bauer@uni-due.de